English
Headspace Oxygen Analyzer
Headspace Oxygen Analyzer

MH-F13 O₂/ DO Gas Analyzer

Principle: Oxygen molecules quench the fluorescence signal emitted by a specialized sensor spot. The degree of signal attenuation is directly proportional to the oxygen concentration.

Methods: 

1) Invasive: A needle containing the sensor spot pierces the package.

2) Non-Invasive: A fluorescent patch is placed inside a sampling dome, which collects gas from the package.

Fill in the information

verify

Application

Features

Technical Specifications

Measurement Range

Headspace O₂:

0-100% (Full-range sensor)

Dissolved O₂:

0-44 mg/L (Full-range sensor)

0-21% (Trace O₂ sensor)

0-9 mg/L (Trace O₂ sensor)

Operating Environment

0–50°C, ≤85% RH, non-condensing.

Accuracy

(2-Point Cal.)

Headspace:

±0.2% abs at 20.9%; ±0.02% abs at 1%;

±(2% of reading or 0.01% abs) for trace sensor.

Dissolved:

±0.01 mg/L at 0.44 mg/L;

±0.1 mg/L at 8.8 mg/L.

Control

Industrial PC

Power Supply

100-240 VAC, 50/60 Hz

Interface

USB

 

Why Choose the MH-F13 Oxygen Analyzer?

 

Measures Both Headspace and Dissolved Oxygen

One oxygen leak detector system supports both headspace oxygen measurement and dissolved oxygen measurement, reducing the need for separate instruments.

Full-Range and Trace Oxygen Measurement

Different sensor configurations allow users to evaluate both normal oxygen concentrations and low-level oxygen conditions.

Suitable for Very Small Headspace Volumes

The oxygen leak detector supports containers with headspace volumes down to approximately 0.1 mL, allowing testing of many small pharmaceutical packages.

Invasive and Non-Invasive Options

Users can select needle-based or dome-based sampling according to the package design.

Low Maintenance Sensor

The fluorescence sensor is designed for extended operation without frequent sensor replacement.

Data Management

The software supports:

● Database storage
● User access control
● Audit trail
● Electronic signatures
● Data export
● PDF and Word reporting

These functions make the MH-F13 suitable for controlled pharmaceutical laboratory environments.

 

Headspace Oxygen vs. Dissolved Oxygen

 

Measurement Headspace Oxygen Dissolved Oxygen
What is measured? Oxygen in package gas space Oxygen dissolved in liquid
Typical unit % O₂ mg/L
Main application Packaging/headspace evaluation Liquid formulation evaluation
Suitable packages Vials, ampoules, bottles, bags Liquid-filled pharmaceutical containers
MH-F13 support Yes Yes

For oxygen-sensitive pharmaceutical products, measuring both parameters can provide a more complete understanding of the oxygen environment inside the package.

 

Need to Measure Headspace or Dissolved Oxygen?

 

Tell Zholion your package type, headspace volume, product characteristics and expected oxygen range.

Our technical team can recommend the appropriate MH-F13 sensor range and sampling configuration for your pharmaceutical oxygen measurement application.

Contact Zholion for MH-F13 Pricing & Technical Evaluation.

More Information

  • Related articles
  • Frequently Asked Questions
  • Q:

    How does ECA stipulate about visible particulates for injectable drugs?

    A:

    4.3 What aspects should be considered when assessing artificially created test kits, and how should their suitability be justified?

    Artificially created test kits are often used when representative production samples are unavailable, technically unsuitable, or cannot be obtained in sufficient quantity for qualification, training, or evaluation purposes.

    Their suitability should be assessed based on the inspection technology used and the required level of representativeness. Artificially created defects and conforming units should exhibit optical, physical, and mechanical characteristics comparable to those of the real product under routine inspection conditions.

    For AI-based inspection systems, higher requirements regarding representativeness may apply, as these systems often utilize very subtle features and characteristics to distinguish between acceptable and defective units. For example, a genuine lyophilized cake with crystalline reflective properties can generally be distinguished from a matte plaster-based imitation if these differences are visible in the image data.

    If artificially created defects differ in relevant characteristics—such as texture, reflectivity, contrast, size, movement behaviour, or other optical or physical properties—there is a risk that the neural network learns features introduced by the artificial manufacturing process rather than the actual defect itself. Likewise, particle detection may be influenced by factors such as viscosity, turbidity, fill height particle size, or particle contrast. These factors should therefore be considered when assessing the suitability of artificially created test kits and may also affect the performance of conventional rule-based inspection systems.

    Conventional rule-based systems are generally less susceptible to such effects because they evaluate predefined image features rather than learning complex representations. Although these approaches are often less selective and may be less suitable for highly challenging inspection tasks, they typically demonstrate greater robustness against variations or realism drifts within artificially created test kits.

    Consequently, the suitability of artificially created test kits should always be justified and documented with regard to the inspection technology and the intended application. The decisive criterion is not whether defects are artificially created or taken from routine production, but whether the test kit reliably reproduces the behaviour of the final drug product under the selected inspection strategy.

  • Q:

    Can one instrument test different package sizes?

    A:

    Yes. Different package sizes and shapes can be tested by changing the test chamber, fixture or sample holder.

  • Q:

    Can the system test pharmaceutical vials?

    A:

    Yes. Vacuum decay testing can be configured for vials containing powder, lyophilized products or medicinal liquids. A package-specific chamber is normally required.

Related Products